Author

Dan Peer

Tel Aviv UniversityORCID 0000-0001-8238-0673Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:imaging· 1 Approach:microscopy & imaging analysis· 1 Organism:mouse· 1

Frequent Co-Authors

Meir GoldsmithiD· 2 shared Mike BismuthiD· 2 shared Tali IlovitshiD· 2 shared Alina BrosqueiD· 1 shared Anna GutkiniD· 1 shared Dana Bar-On· 1 shared Dinorah Friedmann‐MorvinskiiD· 1 shared Divsha Sher· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Meir GoldsmithORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyAdvanced SciencePeer-reviewedSep 27, 2026

Acoustically activatable drug-loaded nanodroplets for mechanochemical therapy in solid tumors

Tiran Bercovici, Mike Bismuth, Meir Goldsmith…·Tali Ilovitsh

This paper develops acoustically activatable nanodroplets for targeted drug delivery and mechanical tumor disruption, showing improved tumor control and survival in vivo.

DOI 10.1002/advs.78010

experimental assaydrug response / drug discovery

𝕏 PostBluesky

BioengineeringJournal of Controlled ReleasePeer-reviewedJul 7, 2025

Low-frequency ultrasound-mediated blood-brain barrier opening enables non-invasive lipid nanoparticle RNA delivery to glioblastoma

Maya Shumer-Elbaz, Nitay Ad‐El, Yulia Chulanova…·Tali Ilovitsh

This paper demonstrates that low-frequency ultrasound can safely open the blood-brain barrier to deliver lipid nanoparticles (LNPs) containing RNA to glioblastoma tumors in mice.

30 citationstop 2%

mousebulk RNA-seq

𝕏 PostBluesky